CryoLife, Inc. (NYSE:CRY)

CAPS Rating: 5 out of 5

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Recs

0
Player Avatar bigchuck27 (< 20) Submitted: 1/19/2009 11:01:50 AM : Outperform Start Price: $7.72 CRY Score: -99.89

Great industry, great fundamentals.

Featured Broker Partners


Advertisement